IMU Share Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.01 100.00
Volume 3368016 1 Year 0.01 100.00
52 Week High 0.02
52 Week Low 0.01
IMU Important Levels
Resistance 2 0.02
Resistance 1 0.02
Pivot 0.02
Support 1 0.02
Support 2 0.02
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
NSL 0.02 0.00%
NSL 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
EVZ 0.02 100.00%
AZM 0.03 50.00%
AZM 0.03 50.00%
AZM 0.03 50.00%
PMQ 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
CSS 0.04 -20.00%
CSS 0.04 -20.00%
CSS 0.04 -20.00%
CSS 0.04 -20.00%
More..

Imugene Ltd (ASX: IMU)

IMU Technical Analysis 5
As on 24th Jul 2017 IMU Share Price closed @ 0.02 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
IMU Target for July
1st Target up-side 0.02
2nd Target up-side 0.02
3rd Target up-side 0.02
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side -0
IMU Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.imugene.com
IMU Address
IMU
1233 High Street
Suite 1
Armadale, VIC 3143
Australia
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
IMU Latest News
Imugene granted Canadian patent for proprietary cancer vaccine   Proactive Investors Australia   - 21st Jul 17
Imugene Ltd (IMU.AX) Needle Moving on Volume   FLBC News   - 20th Jul 17
Support from leading institutional investors augurs well for Imugene   Finfeed   - 07th Apr 17
Imugene receives investor support   NEWS.com.au   - 30th Mar 17
Imugene Limited (ASX:IMU) Encouraging HER-Vaxx Research Published in ...   ABN Newswire (press release)   - 13th Feb 17
Imugene Ltd appoints Leslie Chong to chief executive officer   Proactive Investors Australia   - 22nd Nov 16
Imugene Ltd gets site approval for gastric cancer study in Thailand   Proactive Investors Australia   - 22nd Aug 16
Imugene cashes up ahead of hotly anticipated cancer treatment trials   Proactive Investors Australia   - 28th Oct 15
Imugene Limited on road to raising   Proactive Investors Australia   - 07th Sep 15
Imugene Limited appoints Leslie Chong as chief operating officer   Proactive Investors Australia   - 27th Aug 15
Interactive Technical Analysis Chart Imugene Ltd ( IMU ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Imugene Ltd
IMU Business Profile
Imugene Limited, a pharmaceutical company, is engaged in the research, development, and commercialization of health technologies in Australia. The company’s drug delivery platform technology, Linguet enables the active ingredient of drugs to be absorbed into the bloodstream when placed inside the cheek or under the tongue for the treatment of Vitamin D deficiency, Parkinson’s disease, osteoporosis, pain relief markets of non-steroidal anti-inflammatory drugs. The company is also involved in the development of Vitamin D tablet for buccal delivery; and lead cancer vaccine product targeting gastric cancer and breast cancer. Imugene Limited is based in Armadale, Australia.